SION Latest Press Releases

-- February 23, 2026 --

Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences Globe Newswire 8:00 AM

-- February 4, 2026 --

Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Globe Newswire 7:00 AM

-- January 5, 2026 --

Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 7:00 AM

-- November 24, 2025 --

Sionna Therapeutics to Participate in Upcoming December Investor Conferences Globe Newswire 7:00 AM

-- November 5, 2025 --

Sionna Therapeutics Reports Third Quarter 2025 Financial Results Globe Newswire 7:00 AM

-- November 4, 2025 --

Sionna Therapeutics to Participate in Upcoming November Investor Conferences Globe Newswire 8:00 AM

-- October 24, 2025 --

Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference Globe Newswire 1:15 PM

-- October 21, 2025 --

Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis Globe Newswire 7:00 AM

-- October 1, 2025 --

Sionna Therapeutics to Present Data at the 2025 North American Cystic Fibrosis Conference Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software